Insider trading

Period: 120 months Stock: BDX Minimum amount: $100K × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

119 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

119 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

119 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

119 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
119 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
119 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

119 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
13 Aug 2026
Polen Thomas E Jr Chairman, CEO and President
Sold on a plan
$768.12K 4,152 at 185.00
3.6%
Planned (10b5-1)
11 Aug 2026
Goette Roland EVP and President, EMEA
Sold at will
$440.89K 2,438 at 180.84
14.1%
Not planned
24 Jun 2026
Garrison Michael David EVP & Pres Med.Essntl&BioPharm
Sold on a plan
$160.23K 1,100 at 145.66
7.7%
Planned (10b5-1)
10 Jun 2026
Garrison Michael David EVP & Pres Med.Essntl&BioPharm
Sold on a plan
$166.63K 1,100 at 151.48
7.2%
Planned (10b5-1)
1 Jun 2026
Polen Thomas E Jr Chairman, CEO and President
Sold on a plan
$404.51K 2,764 at 146.35
2.4%
Planned (10b5-1)
18 Feb 2026
SCOTT BERTRAM L Director
Sold at will
$174.03K 953 at 182.61
2.5%
Not planned
15 Jan 2026
Garrison Michael David EVP & Pres Med.Essntl&BioPharm
Sold on a plan 2×
$334.01K 1,610 at 207.46
11.7%
Planned (10b5-1)
17 Dec 2025
Garrison Michael David EVP & Pres Med.Essntl&BioPharm
Sold on a plan
$123.30K 629 at 196.03
4.6%
Planned (10b5-1)
10 Sep 2025
Fraser Claire Director
Sold at will
$171.94K 917 at 187.50
4.0%
Not planned
11 Aug 2025
HAYES GREGORY Director
Bought
$1.01M 5,250 at 191.57
660%
First buy on file
8 Aug 2025
Fraser Claire Director
Sold at will
$165.95K 863 at 192.30
3.6%
Not planned
18 Jul 2025
Garrison Michael David EVP & President, Medical
Sold on a plan 2×
$213.64K 1,185 at 180.29
19.5%
Planned (10b5-1)
2 Jun 2025
Shan David EVP and Chief ISC Officer
Sold on a plan
$199.61K 1,166 at 171.19
20.3%
Planned (10b5-1)
18 Mar 2025
Byrd Richard EVP & President Interventional
Sold on a plan
$105.57K 459 at 230.00
6.2%
Planned (10b5-1)
12 Mar 2025
Byrd Richard EVP & President Interventional
Sold on a plan
$436.33K 1,940 at 224.91
20.7%
Planned (10b5-1)
12 Feb 2025
SCOTT BERTRAM L Director
Sold at will
$159.59K 700 at 227.99
1.9%
Not planned
10 Feb 2025
Bought
$350.43K 1,500 at 233.62
23.0%
First buy on file
21 Jan 2025
Neal Shana Carol EVP and Chief People Officer
Sold on a plan
$188.88K 787 at 240.00
4.9%
Planned (10b5-1)
21 Jan 2025
Shan David EVP and Chief ISC Officer
Sold on a plan
$120.00K 500 at 240.00
8.0%
Planned (10b5-1)
17 Jan 2025
Garrison Michael David EVP & President, Medical
Sold on a plan
$141.20K 597 at 236.51
9.7%
Planned (10b5-1)
7 Jan 2025
Neal Shana Carol EVP and Chief People Officer
Sold on a plan
$185.18K 788 at 235.00
4.6%
Planned (10b5-1)
19 Dec 2024
Garrison Michael David EVP & President, Medical
Sold on a plan
$633.81K 2,838 at 223.33
31.6%
Planned (10b5-1)
9 Dec 2024
Goette Roland EVP and President, EMEA
Sold on a plan
$139.74K 638 at 219.03
4.3%
Planned (10b5-1)
6 Dec 2024
Goette Roland EVP and President, EMEA
Sold on a plan
$990.79K 4,483 at 221.01
15.6%
Planned (10b5-1)
6 Dec 2024
Neal Shana Carol EVP and Chief People Officer
Sold on a plan
$220.49K 1,000 at 220.49
5.6%
Planned (10b5-1)
5 Dec 2024
Shan David EVP and Chief ISC Officer
Sold on a plan
$330.38K 1,500 at 220.25
19.3%
Planned (10b5-1)
15 May 2024
Goette Roland EVP and President EMEA
Sold on a plan 3×
$781.22K 3,300 at 236.73
22.6%
Planned (10b5-1)
13 May 2024
Goette Roland EVP and President EMEA
Sold on a plan 3×
$781.12K 3,300 at 236.70
18.4%
Planned (10b5-1)
30 Apr 2024
Garrison Michael David EVP & President Medical
Sold on a plan
$399.27K 1,715 at 232.81
24.2%
Planned (10b5-1)
11 Dec 2023
Garrison Michael David EVP & President Medical
Sold on a plan
$288.02K 1,239 at 232.46
14.6%
Planned (10b5-1)
28 Nov 2023
Byrd Richard EVP & President Interventional
Sold on a plan
$514.14K 2,156 at 238.47
34.4%
Planned (10b5-1)
5 Sep 2023
Byrd Richard EVP & President Interventional
Sold on a plan
$125.99K 459 at 274.48
11.8%
Planned (10b5-1)
28 Aug 2023
Fraser Claire Director
Sold at will
$238.85K 848 at 281.66
3.8%
Not planned
11 Aug 2023
Hickey David EVP & President, Life Sciences
Sold on a plan
$826.33K 2,974 at 277.85
41.5%
Planned (10b5-1)
8 Aug 2023
Garrison Michael David EVP & President Medical
Sold on a plan
$360.27K 1,300 at 277.13
20.1%
Planned (10b5-1)
3 Feb 2023
Byrd Richard EVP & President Interventional
Sold, plan not stated
$353.26K 1,421 at 248.60
25.6%
15 Aug 2022
Polen Thomas E Jr Chairman, CEO and President
Sold, plan not stated
$2.52M 9,500 at 265.13
24.8%
15 Aug 2022
Hickey David EVP & President, Life Sciences
Sold, plan not stated
$125.88K 475 at 265.00
12.5%
9 Aug 2022
Khichi Samrat S. EVP and General Counsel
Sold, plan not stated
$2.39M 9,185 at 260.44
60.8%
Sold half or more
9 Aug 2022
Polen Thomas E Jr Executive Vice President
Sold, plan not stated
$429.52K 1,652 at 260.00
5.4%
8 Aug 2022
Khichi Samrat S. EVP and General Counsel
Sold, plan not stated
$1.90M 7,295 at 260.44
55.2%
Sold half or more
7 Jun 2022
Spoerel Thomas J VP Controller & Chief Acct Off
Sold, plan not stated
$115.18K 443 at 260.00
29.5%
6 May 2022
Hickey David EVP & President, Life Sciences
Sold, plan not stated
$121.60K 475 at 256.00
11.1%
25 Feb 2022
Larson Betty D EVP HR & CHRO
Sold, plan not stated 8×
$3.91M 14,374 at 271.90
71.0%
Sold half or more
8 Feb 2022
Fraser Claire Director
Sold, plan not stated
$228.50K 841 at 271.70
3.8%
3 Feb 2022
Conroy Alexandre EVP of Integrated Supply Chain
Sold, plan not stated
$1.73M 6,410 at 270.16
23.2%
16 Dec 2021
Larson Betty D EVP HR & CHRO
Sold, plan not stated 2×
$851.96K 3,341 at 255.00
36.3%
8 Sep 2021
RIMEL REBECCA W Director
Sold, plan not stated
$130.00K 500 at 260.00
4.5%
8 Sep 2021
Hickey David EVP & President, Life Sciences
Sold, plan not stated
$130.00K 500 at 260.00
12.2%
3 Sep 2021
Lim James C Executive Vice President
Sold, plan not stated
$1.79M 6,956 at 257.44
26.0%
Showing 1–50 of 119. Page 1 of 3 Older →